10 Undervalued Counter Cyclical Stocks to Buy Now
Counter-cyclical stocks are getting more attention as investors look for businesses tied to demand that does not disappear just because the economy slows.
Posts Tagged ‘Gilead Sciences Inc. (NASDAQ:GILD)’
Top 10 Income Stocks with the Highest Upside Potential
Growth is often the primary objective of an investment strategy.
10 Most Undervalued Quality Stocks to Invest In
On June 10, Tom Lee, Fundstrat, joined CNBC's 'Closing Bell' to discuss the current state of the market, and noted that it is showing signs of jitters due to the SpaceX IPO and...
7 Best Longevity Stocks to Buy Now
Longevity stocks are getting more attention as investors look for companies tied to longer lifespans, healthier aging, and rising demand for care.
Top 10 Large Cap Value Stocks to Buy Now
On June 9, Tom Lee, Fundstrat Managing Partner, appeared on CNBC's 'Power Lunch' to discuss the latest market action.
10 Deep Value Stocks to Invest In Now
Value stocks are on the move, after years of underperformance, amid heightened market volatility and a shift away from mega-cap concentration.
8 Best Quality Growth Stocks to Buy
On June 2, Dan Niles, Niles Investment Management, joined 'Closing Bell Overtime' on CNBC to talk parabolic moves in the tech trade and what these massive gains signal.
Gilead Sciences (GILD) Announces New Results From a Post Hoc Analysis
Gilead Sciences, Inc. (NASDAQ:GILD) is one of the best inexpensive stocks to invest in right now. Gilead Sciences, Inc.
Gilead Sciences, Inc. (GILD) Gains Attention as Livdelzi Demonstrates Long-Term Efficacy and Safety
TheFly reported on May 27 that GILD presented long-term interim findings from the ongoing Phase 3 ASSURE study of Livdelzi at the 2026 European Association for the Study of ...
9 Best Inexpensive Stocks to Invest In Right Now
She thinks that we have reason to be exuberant, as we are in the middle of an incredible rate of change of technology and innovation, and so it is not bad.
10 Safest Dividend Stocks to Buy Right Now
Securing a predictable income while managing volatility is becoming the most adopted strategy for investors in the increasingly challenging economic environment.
11 Most Undervalued Pharma Stocks to Invest In
Haig Bathgate, CEO of Callanish Capital, stated on CNBC on May 7 that he is confident about global stocks despite worries over the Iran war.
12 Most Profitable Stocks to Invest In
Profitable stocks are getting more attention as investors focus on companies that can keep producing earnings even when rates, costs, and demand trends shift.
10 Cheap NASDAQ Stocks to Buy Right Now
On April 28, Gabelli's John Belton joined CNBC's 'Closing Bell Overtime' to analyze the market environment heading into earnings season.
12 Best Dividend Stocks to Invest In According to Hedge Funds
Investors tend to favor dividend stocks in times of market volatility and economic uncertainty, as we have seen in recent months.
14 Best Extremely Profitable Stocks to Buy According to Wall Street Analysts
More than two-thirds into the first-quarter reporting season, S&P 500 companies are set to report their strongest quarterly earnings growth in over four years, Reuters reported...
10 Best Long Term Low Risk Stocks to Buy According to Hedge Funds
In its report on low-risk investments, TD Asset Management said low-volatility investing can help reduce downside risk while still delivering solid long-term returns.
Gilead Sciences, Inc. (GILD) Outlook Cut Sharply on $11.5B IPR&D and Financing Costs
TheFly reported on May 7 that GILD revised its fiscal 2026 outlook, now expecting adjusted earnings per share between a loss of $1.05 and a loss of $0.65, compared with prior ...
10 Best Cancer Stocks to Buy for the Long Term
Pharmaceutical firms have always had a special place in the healthcare market because they provide stability and expansion.
Gilead Sciences (GILD) Set to Acquire Arcellx
Gilead Sciences, Inc. (NASDAQ:GILD) is one of the best stem cell therapy stocks to buy. Gilead Sciences, Inc.
8 Best Stem Cell Therapy Stocks to Buy
On April 23, Bankim Chadha, chief global strategist at Deutsche Bank, appeared on CNBC's ‘Money Movers’ to talk about uncertainty in the markets and what to expect with the...
14 Best Defensive Stocks to Invest In Now
The US economy has entered the final week of April navigating a precarious war-driven landscape that has fundamentally altered the outlook for both growth and monetary policy.
Morgan Stanley Adjusts Gilead Sciences, Inc. (GILD) Outlook Ahead of Q1 Earnings
TheFly reported on April 10 that Morgan Stanley increased its price target for GILD to $175 from $171 while maintaining an Overweight rating.
Jim Cramer’s 11 Stocks Review: HOOD, WFC, and Market Rotation
In this article, we will look at the stocks Jim Cramer reviewed on Mad Money while discussing the recent market rotation.
10 Best Healthcare Stocks to Buy and Hold for 3 Years
The first quarter of this year has seen a great deal of volatility in the equity markets.
10 Healthcare Stocks with Highest Dividends
In December, CNBC reported that health-care job growth is propping up the labor market at a time when many other industries are struggling.
13 NASDAQ Stocks with Highest Dividends
In recent years, technology markets have drawn more attention from investors around the world, especially those linked to the NASDAQ Composite Index.
8 Best Quality Stocks to Buy According to Hedge Funds
On April 9, Tom Lee of Fundstrat appeared on CNBC's 'Closing Bell' to suggest that the market has reached a bottom.
7 Most Profitable Value Stocks to Buy Right Now
On April 2, Kevin Mahn, Hennion & Walsh Asset Management president and chief investment officer, joined 'Squawk Box' on CNBC to discuss market reactions to developments in the...
15 Best Low Volatility Blue Chip Stocks to Buy Now
The S&P 500 has declined by over 3.5% in 2026 so far. According to an April 1 report by CNBC, investors were being urged to brace for more volatility.
Dividend Stock Portfolio for Income: 15 Stocks to Invest In
Growth often takes center stage in an investing strategy. Still, for many investors, income can matter just as much, sometimes even more.
Gilead Sciences, Inc. (GILD): Growth Prospects Backed by Analyst Upgrades
Gilead Sciences Inc. (NASDAQ:GILD) is one of Goldman Sachs top healthcare stocks. On March 10, Jefferies initiated coverage of Gilead Sciences Inc.
Goldman Sachs Healthcare Stocks: Top 10 Stock Picks
The healthcare sector, long seen as a laggard amid the artificial intelligence boom, is beginning to turn the corner.
Barclays Takes Neutral Stance on Gilead Sciences (GILD) Despite Strategic Refocus
On February 20, Barclays began coverage of Gilead Sciences, Inc. (NASDAQ:GILD) with an Equal Weight rating. The firm set a $155 price target on the stock.
13 Best NASDAQ Dividend Stocks to Buy Now
In recent years, technology markets, especially those tracked by the NASDAQ Composite Index, have drawn growing attention from investors around the world.
What Do Analysts Have to Say About Gilead Sciences (GILD) Post Earnings?
Gilead Sciences, Inc. (NASDAQ:GILD) is one of the best immunotherapy stocks to buy according to hedge funds. Gilead Sciences, Inc.
12 Best Immunotherapy Stocks to Buy According to Hedge Funds
On February 13, Matt Orton, Raymond James Investment Management's chief market strategist, appeared on CNBC’s ‘The Exchange’ to talk about the recent trends in equity markets...
BofA Raises PT on Gilead Sciences (GILD) to $162 From $154 – Here’s Why
Gilead Sciences, Inc. (NASDAQ:GILD) is one of the best medical research stocks to buy according to hedge funds.
10 Best Medical Research Stocks to Buy According to Hedge Funds
On January 27, Sarah James, Cantor Fitzgerald analyst, appeared on CNBC’s ‘Squawk on the Street’ to talk about the healthcare insurance sector and the stocks coming under...
Truist Securities Raises Price Target on Gilead Sciences, Inc. (GILD) to $145, Keeps Buy Rating
Gilead Sciences, Inc. (NASDAQ:GILD) is among the 12 Most Profitable NASDAQ Stocks to Buy Right Now.
UBS Turns More Bullish on Gilead Sciences, Inc. (GILD) Amid Positive Pharma Sector Outlook
Gilead Sciences, Inc. (NASDAQ:GILD) is among the most profitable healthcare stocks to buy. On January 26, UBS lifted the price target on Gilead Sciences, Inc.
12 Most Profitable NASDAQ Stocks to Buy Right Now
2025 was another stellar year for the markets, marking the third successive instance of double-digit returns for the indices.
10 Most Profitable Healthcare Stocks to Buy
By far, the healthcare sector remains among the most resilient and profitable in global equity markets.
UBS and Citi Go Bullish on Gilead Sciences (GILD)
On January 7, 2026, reports highlighted that analysts are increasingly confident in Gilead Sciences, Inc.
11 Most Undervalued Blue Chip Stocks to Buy Now
As we enter 2026, U.S. equities are expected to enter a phase marked by several complexities following the outsized gains in 2025.
Morgan Stanley Expects Gilead Sciences (GILD) to Thrive as Biopharma Policy Uncertainties Fade in 2026
Gilead Sciences Inc. (NASDAQ:GILD) is one of the best stocks for the next decade.
Gilead (GILD) Reaches Pricing Agreement with US Government to Lower Drug Costs
On December 19, Gilead Sciences, Inc. (NASDAQ:GILD) announced an agreement with the US government aimed at lowering drug costs for Americans.
Is Gilead Sciences (GILD) An Affordable Healthcare Stocks to Invest In?
Gilead Sciences, Inc. (NASDAQ:GILD) is one of the best affordable healthcare stocks to buy now. Gilead Sciences, Inc.
14 Best Pharma Dividend Stocks to Buy in 2026
For most drugmakers, the US is the largest single market. Prices there are often close to three times higher than in other developed countries.
Long-Term Stock Portfolio: 10 Best Stocks for the Next Decade
On December 16, Julian Emanuel, Senior Managing Director at Evercore ISI, shared his outlook on the equity market and the ongoing influence of AI.
Hedge Fund Resource Center
